Acesion Pharma raises 9.1 million EUR in first closing of new funding from Novo Seeds and Wellcome T
Acesion Pharma, a Danish biotech company developing novel treatments for atrial fibrillation (AF), today announced that it has raised 9.1...
top of page
- Sep 30, 2016
- 1 min
Acesion Pharma appoints experienced CMC executive Breian Knudsen as VP CMC
Acesion Pharma, a pharmaceutical company developing novel first-in-class drugs to treat atrial fibrillation (AF), announced today that it...
5 views
- Jul 31, 2016
- 1 min
Acesion Pharma appoints experienced clinical leader Christina Sylvest as SVP acute cardioversion
Acesion Pharma, a pharmaceutical company developing novel first-in-class drugs to treat atrial fibrillation (AF), announced today that it...
2 views
LATEST NEWS
bottom of page